$CRTG
CORETEC GROUP INC.

2023 Q1 Form 10-K Financial Statement

#000143774923007024 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $347.2K $960.5K $2.133M
YoY Change -19.88% 249.65% -62.01%
% of Gross Profit
Research & Development $111.9K $135.3K $535.8K
YoY Change -43.62% 224.1% 14.01%
% of Gross Profit
Depreciation & Amortization $2.373K $23.03K $6.803K
YoY Change 2296.97% 11.47%
% of Gross Profit
Operating Expenses $111.9K $1.091M $535.8K
YoY Change -43.62% 245.25% 14.01%
Operating Profit
YoY Change
Interest Expense $54.08K -$54.48K $202.8K
YoY Change 12.69% -0.06% -11.66%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$507.4K -$1.145M -$2.863M
YoY Change -25.31% 209.16% -54.33%
Income Tax
% Of Pretax Income
Net Earnings -$507.4K -$1.145M -$2.863M
YoY Change -25.31% 209.16% -54.33%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 268.9M 267.6M 258.3M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.943M $2.356M $2.356M
YoY Change -45.42% -41.87% -41.87%
Cash & Equivalents $1.943M $2.356M
Short-Term Investments
Other Short-Term Assets $56.67K $114.2K $114.2K
YoY Change -46.41% -14.45% -14.45%
Inventory
Prepaid Expenses $56.67K $114.2K
Receivables
Other Receivables
Total Short-Term Assets $2.000M $2.471M $2.471M
YoY Change -45.45% -40.99% -40.99%
LONG-TERM ASSETS
Property, Plant & Equipment $71.09K $73.46K $73.46K
YoY Change 1117.9%
Goodwill $166.0K $166.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.550K $4.550K $4.550K
YoY Change -93.42% -72.15% -72.15%
Total Long-Term Assets $1.128M $1.151M $1.151M
YoY Change -6.78% -1.79% -1.79%
TOTAL ASSETS
Total Short-Term Assets $2.000M $2.471M $2.471M
Total Long-Term Assets $1.128M $1.151M $1.151M
Total Assets $3.128M $3.622M $3.622M
YoY Change -35.86% -32.42% -32.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $345.2K $317.0K $317.0K
YoY Change -14.0% 3.22% 3.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $30.90K $61.40K $61.40K
YoY Change
Long-Term Debt Due $67.74K $0.00
YoY Change
Total Short-Term Liabilities $443.8K $378.4K $378.4K
YoY Change 10.58% 23.22% 23.21%
LONG-TERM LIABILITIES
Long-Term Debt $1.363M $1.415M $1.415M
YoY Change 13.4% 19.14% 19.14%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.363M $1.415M $1.415M
YoY Change 13.4% 19.14% 19.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $443.8K $378.4K $378.4K
Total Long-Term Liabilities $1.363M $1.415M $1.415M
Total Liabilities $1.807M $1.793M $1.793M
YoY Change 12.69% 19.98% 19.98%
SHAREHOLDERS EQUITY
Retained Earnings -$16.85M -$16.35M
YoY Change 19.01% 21.24%
Common Stock $53.77K $53.77K
YoY Change 5.19% 5.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.321M $1.828M $1.828M
YoY Change
Total Liabilities & Shareholders Equity $3.128M $3.622M $3.622M
YoY Change -35.86% -32.42% -32.42%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$507.4K -$1.145M -$2.863M
YoY Change -25.31% 209.16% -54.33%
Depreciation, Depletion And Amortization $2.373K $23.03K $6.803K
YoY Change 2296.97% 11.47%
Cash From Operating Activities -$382.4K -$492.1K -$1.849M
YoY Change -21.39% 61.97% 65.93%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $80.27K
YoY Change -100.0% -768.32%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$80.27K
YoY Change -100.0% 568.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.50K 72.38K $232.2K
YoY Change -95.5%
NET CHANGE
Cash From Operating Activities -$382.4K -492.1K -$1.849M
Cash From Investing Activities 0.000 0.000 -$80.27K
Cash From Financing Activities -30.50K 72.38K $232.2K
Net Change In Cash -$412.9K -419.7K -$1.697M
YoY Change -16.14% 38.15% -142.1%
FREE CASH FLOW
Cash From Operating Activities -$382.4K -$492.1K -$1.849M
Capital Expenditures $0.00 $0.00 $80.27K
Free Cash Flow -$382.4K -$492.1K -$1.929M
YoY Change -22.34% 61.97% 75.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001375195
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
4118214 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
268871202
CY2022 dei Auditor Firm
AuditorFirmId
483
CY2022 dei Auditor Name
AuditorName
HOGANTAYLOR LLP
CY2022 dei Auditor Location
AuditorLocation
Tulsa, Oklahoma
CY2022Q4 us-gaap Cash
Cash
2356348 usd
CY2021Q4 us-gaap Cash
Cash
4053327 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
114201 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133491 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2470549 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4186818 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73462 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
906975 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
989604 usd
CY2022Q4 us-gaap Goodwill
Goodwill
166000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
166000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
4550 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16343 usd
CY2022Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1077525 usd
CY2021Q4 crtg Assets Excluding Property And Equipment Noncurrent
AssetsExcludingPropertyAndEquipmentNoncurrent
1171947 usd
CY2022Q4 us-gaap Assets
Assets
3621536 usd
CY2021Q4 us-gaap Assets
Assets
5358765 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
61398 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
316992 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
307096 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
378390 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307096 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1414826 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1793216 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1494614 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
345000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
345000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
69 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
268871202
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
268871202
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
254055581
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
254055581
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
53772 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
50809 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18119792 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17295262 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16345313 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13481989 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1828320 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3864151 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3621536 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5358765 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
469996 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
8260 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2863324 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-6268939 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.026
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
258337996
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
243964924
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
736957 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
862775 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
265458 usd
CY2021 crtg Stock Issued During Period Value Issued For Liabilities
StockIssuedDuringPeriodValueIssuedForLiabilities
94851 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
323223 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4913200 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
62785 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4599391 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4102 usd
CY2022 crtg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1030 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
761695 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
761695 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4599391 usd
CY2022 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
0 usd
CY2021 crtg Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
323223 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-19289 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-46472 usd
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-11793 usd
CY2021 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-2603 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
70563 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5930 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1848892 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1114230 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80265 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12007 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80265 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12007 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
40046 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
90505 usd
CY2022 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
271194 usd
CY2021 crtg Proceeds From Debt And Warrants Issued
ProceedsFromDebtAndWarrantsIssued
334650 usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1030 usd
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4913200 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
232178 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5157345 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1696979 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4031108 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4053327 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22219 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
106783 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
92434 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
265458 usd
CY2022 crtg Stock Options Exchanged For Common Stock
StockOptionsExchangedForCommonStock
180 usd
CY2022 crtg Stock Issued To Settle Liabilities From Services Received
StockIssuedToSettleLiabilitiesFromServicesReceived
60666 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<i>Use of Estimates</i>The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
254942697
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
236266997
crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
9500000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
266598 usd
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8033313 usd
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7339175 usd
crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
5700000
CY2021Q3 crtg Stock Cancelled And Reissued During Period
StockCancelledAndReissuedDuringPeriod
23000000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.105
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
24000000
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0277
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
61398 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1414826 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1187518 usd
CY2022 crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
15385 usd
CY2021 crtg Amortization Associated With Commitment Fee
AmortizationAssociatedWithCommitmentFee
14125 usd
CY2020Q2 crtg Share Exchange Agreement Number Of Options Authorized
ShareExchangeAgreementNumberOfOptionsAuthorized
21500000
CY2020Q2 crtg Share Exchange Agreement Exchange Ratio
ShareExchangeAgreementExchangeRatio
0.6 pure
CY2022 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
1500000
CY2021 crtg Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExchanged
5000000
CY2022 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
900000
CY2021 crtg Stock Issued During Period Shares Stock Options Exchanged For Common Shares
StockIssuedDuringPeriodSharesStockOptionsExchangedForCommonShares
3000000
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
142604000
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0515
CY2022 crtg Class Of Warrant Or Right Issued Monthly
ClassOfWarrantOrRightIssuedMonthly
210000
CY2022 crtg Class Of Warrant Or Right Issued During Period Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
0.0520
CY2022 crtg Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
10300000
CY2022 crtg Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
0.0001
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
132514000
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0555
CY2022 crtg Class Of Warrant Or Right Contractual Term
ClassOfWarrantOrRightContractualTerm
P3Y7M17D
CY2022Q4 crtg Class Of Warrant Or Right Intrinsic Value
ClassOfWarrantOrRightIntrinsicValue
1745850 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
24000000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
761695 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4599391 usd
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
77158160
CY2022 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P3Y8M19D
CY2022Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
77158160
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
41175 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
13740 usd

Files In Submission

Name View Source Status
0001437749-23-007024-index-headers.html Edgar Link pending
0001437749-23-007024-index.html Edgar Link pending
0001437749-23-007024.txt Edgar Link pending
0001437749-23-007024-xbrl.zip Edgar Link pending
crtg-20221231.xsd Edgar Link pending
crtg20221231_10k.htm Edgar Link pending
ex_487296.htm Edgar Link pending
ex_487297.htm Edgar Link pending
ex_487298.htm Edgar Link pending
ex_487299.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
crtg-20221231_cal.xml Edgar Link unprocessable
crtg-20221231_def.xml Edgar Link unprocessable
crtg-20221231_pre.xml Edgar Link unprocessable
crtg20221231_10k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crtg-20221231_lab.xml Edgar Link unprocessable